ERBB2 and breast cancer: There were no differences in SUVmax among BC patients with different HER2/neustatuses in mALNs (6.2 ± 4.2 for positive expression and 3.4 ± 2.4for negative expression) (p = 0.1230, Mann–Whitneytest).